Sustainability and impact of warfarin compliance for atrial fibrillation.
Kuo
Sylvia
S
Center for Gerontology and Healthcare Research, The Warren Alpert Medical School of Brown University, Providence, RI 02912, USA. Sylvia_Kuo@brown.edu
Burrill
James
J
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007345:Insurance Claim Review; D038801:International Classification of Diseases; D019934:International Normalized Ratio; D002546:Ischemic Attack, Transient / Q000209:etiology / Q000517:prevention & control*; D008875:Middle Aged; D010349:Patient Compliance / Q000706:statistics & numerical data*; D012237:Rhode Island; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use*
D000925:Anticoagulants; D014859:Warfarin